Journal of Clinical Trials
Open Access
ISSN: 2167-0870
ISSN: 2167-0870
Department of Research & Development, Shreepad Shree Vallabh SSV Phytopharmaceuticals, COO, Particle Life Sciences Pvt. Ltd, Mumbai, Maharashtra, India
Dr. Yogesh Arun Dound is currently working in Department of Research & Development, Shreepad Shree Vallabh SSV Phytopharmaceuticals, COO, Particle Life Sciences Pvt. Ltd, Mumbai, Maharashtra, India. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work.
Research Article
A Randomized, Comparative Clinical Study to Evaluate the Activity of CurvicTM Formulation for Management of SARS-COV-2 Infection
(COVID-19)
Author(s): Yogesh Arun Dound*, Sagar Mandlik, Shrikant Suryavanshi, Rajesh Sehgal and Ajay Naik
COVID-19 outbreak has put forward a huge challenge in front of researchers across the globe. Non availability of any vaccine
or drug has worsened the situation and it has become a worst pandemic of modern times. Keeping scientific rationale and
results of in silico studies, Researchers at Shreepad Shree Vallabh SSV Phytopharmaceuticals (SSV) have developed formulation
containing natural ingredients viz Curcumin, Vitamin C, Vitamin K2-7 and L-Selenomethionine.
Objective: To evaluate role of Curvic TM in the management of COVID-19 and its tolerability in comparison with standard
treatment available from Ministry of Health and Family Welfare (MOHFW).
Study design and methodology: In a randomized, two arm, comparative study, COVID-19 positive patients (n=200) were
enrolled during the month of August and S.. View More»